Biotech
Human history has been all but defined by death and disease, plague and pandemic. Advancements in 20th century medicine changed all of that. Now advancements in 21st century medicine promise to go even further. Could we bring about an end to disease? Reverse aging? Give hearing to the deaf and sight to the blind? The answer may be yes. And soon.
More
Injectable gel repairs severe spinal cord injuries and enables mice to walk
An injectable gel that prevents scar formation and stimulates regeneration successfully repaired severe spinal cord injuries in mice.
Study finds mindfulness as effective as medication for anxiety
An intensive form of mindfulness was found as effective as Lexapro in treating anxiety in adults in the first head-to-head comparative study.
Moderna to develop mRNA vaccines for Ebola
Moderna is reportedly nearing a deal with the DoD to develop mRNA vaccines for biological threats like Ebola
New “risky” playground could make kids anti-fragile
A new playground in Melbourne’s Southbank is the work of artist Mike Hewson, who introduces “risk” back into play.
Our ancestors first developed humanlike brains 1.7 million years ago
Using computed tomography, a team of researchers generated images of what the brains of early Homo species likely looked like.
Cheap blood pressure med could help treat alcoholism
Spironolactone, a cheap medication used to treat high blood pressure, might also be able to help people overcome alcohol use disorder.
New deep brain stimulator is powered automatically by breathing
A deep brain stimulator powered by breathing could eliminate the need for patients to undergo regular battery-change surgeries.
Brain implant translates neural activity into letters, letting a paralyzed man “speak”
A new device allowed a paralyzed patient to “speak,” spelling out full sentences in real-time with an error rate of about 8%.
Old herpes drug helps kill deadly superbug
The anti-herpes drug edoxudine can weaken the deadly superbug K-pneumoniae, potentially offering a new weapon against antibiotic resistance.
Spinal cord stimulation helps paralyzed patients walk again
Swiss researchers have used epidural electrical stimulation to restore walking in nine people with chronic spinal cord injuries.
Doctors may not be ready for blood tests that screen for multiple cancers at once
MCED tests are different from existing ones because they are trying to detect early-stage cancer, when there aren’t that many tumor cells.
Yale’s new nasal vaccine can boost an mRNA shot
A nasal vaccine delivered as a booster to mRNA shots might offer better protection against COVID-19 and help stop the virus from spreading.
African researchers push for a human challenge trial to fight TB
Tuberculosis kills over a million people a year. Researchers in Malawi are pushing for a clinical trial that may help change that.
Chernobyl fungus could shield astronauts from cosmic radiation
A recent study tested how well the fungi species Cladosporium sphaerospermum blocked cosmic radiation aboard the International Space Station.
Australian man uses brain implant to send texts from his iPad
The Stentrode — a brain-computer interface implanted through minimally invasive surgery — has been used to send text messages from an iPad
A new therapy sends lupus into remission
Five patients in Germany had their lupus wiped out by CAR T-cell therapy.
Engineered bacteria may fight this brain-damaging genetic disorder
A possible phenylketonuria therapy using engineered bacteria has shown positive results in a small phase 2 trial.
A malaria-fighting antibody has passed phase 2 trials
An antibody designed to prevent malaria infection has proven effective in phase 2 trials in Mali.
UK trials world’s first lab-grown blood transfusions
UK researchers have launched the world’s first trial in which lab-grown blood cells are being transfused into another person.
“Laughing gas” may offer quick, long-lasting relief from depression
With ketamine showing potential as an antidepressant, researchers investigate another anesthetic: nitrous oxide, or “laughing gas.”
Subscribe to the newsletter